Alternate splicing (AS) defects that adversely impact gene manifestation and function have already been identified in diabetic hearts; however the mechanisms responsible are largely unidentified. to diabetes and takes place at early stages before cardiomyopathy symptoms show up. Importantly DN RBFOX2 Tenacissoside G manifestation impairs intracellular calcium launch in cardiomyocytes. Our outcomes demonstrate that RBFOX2… Continue reading Alternate splicing (AS) defects that adversely impact gene manifestation and function